Abu Dhabi Health Services Company (SEHA), a PureHealth subsidiary, the largest integrated healthcare platform in the Middle East, will host the  Best of ASCO UAE 2023 Conference from 24 to 25 June at Grand Hyatt Abu Dhabi Hotel and Residencies Emirates Pearl. The event will be organised by Abu Dhabi’s Tawam Hospital, which is operated by Abu Dhabi Health Services Company (SEHA). The event will serve as the official annual meeting review of the American Society of Clinical Oncology (ASCO), updating healthcare professionals on the latest advancements in cancer treatment.

Welcoming more than 300 registered delegates from the region and beyond, the two-day conference provides attendees with valuable, actionable insights, and the opportunity to connect with one of the largest, most diverse audiences in global oncology. The event’s agenda consists of presentations on the latest developments in cancer care and will highlight the most advanced treatments, products, and services in oncology.

Saeed Jaber Al Kuwaiti, Group Chief Executive Officer, SEHA, said: “The Best of ASCO UAE 2023 Conference will give an insightful exploration of the most recent scientific breakthroughs and game-changing advancements in cancer treatment.”

Dr. Khalid Balaraj, Chair of the Oncology Center, Tawam Hospital, and Conference Chair, said: “This oncology conference is carefully designed to educate clinicians regarding the latest updates in the field. Our expert faculty will provide an overview of the latest developments, with those selected for presentation and discussion reflecting the foremost research and strategies in oncology, set to impact clinical practice and patient care. Participants will have the opportunity to attend in-depth presentations, and participate in live panel discussions.”

Dr. Sultan Mohammed Al Karam, CEO, Tawam Hospital, said: “We’re very proud to be organising the Best of ASCO UAE 2023 Conference. This purposeful and innovative event will bring together the most influential experts and specialists in oncology, from the UAE and abroad. Our goal will always be to positively transform the services of the UAE’s healthcare system and to give our community access to world-class treatments that enhance their well-being and maintain their health. SEHA’s important continuing medical education initiatives, organising events such as this, are a key priority so that we can continue to advance the fight against complex diseases like cancer.”

Tawam Hospital has one of the UAE’s leading oncology centres, driven by the latest breakthroughs and methodologies, and striving to remain at the forefront of cancer care and research. It is operated by SEHA, an independent public joint stock company created to develop the curative activities of the public healthcare system in Abu Dhabi, which owns and operates all of the public hospitals and clinics in the emirate.

As a subsidiary of PureHealth, SEHA is part of its mission to raise the benchmarks in healthcare excellence, facilitate the development of cutting-edge healthcare solutions, advance the science of longevity, and help people live longer, healthier, happier, and fuller lives. As part of PureHealth’s efforts, SEHA is able to offer the most advanced healthcare possible, utilising technology, and involving highly skilled medical, technical, and administrative staff, greatly improving patient outcomes.

With a diverse portfolio encompassing over 25 hospitals, 100 clinics, multiple diagnostic centres, insurance solutions, pharmacies, health tech, and procurement, PureHealth’s aim is to introduce the healthcare of the future from the UAE to the world and strengthen the country’s position as the global hub for healthcare. This comprehensive approach aligns with its mission to pushing the boundaries for humankind through innovation and transformation within the healthcare sector.

For Best of ASCO UAE registration, visit: https://bascouae.com